MAUNA KEA TECH : Mauna Kea Technologies: 2013 Financial Calendar

Regulatory News:

Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today its schedule for the publication of financial information for 2013.

Event		Date *
2012 Full-Year Sales		Tuesday January 15, 2013
2012 Full-Year Results		Tuesday March 26, 2013
2013 First-Quarter Sales		Tuesday April 16, 2013
Annual General Meeting		Wednesday June 19, 2013
2013 First-Half Sales		Tuesday July 16, 2013
2013 First-Half Results		Friday August 30, 2013
2013 Third-Quarter Sales		Thursday October 10, 2013

* Subject to modification. Press releases are published after market closes.

About Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company dedicated to the advent of optical biopsy. The company researches, develops and markets innovative tools to visualize and detect cellular abnormalities during endoscopic procedures. Its flagship product, Cellvizio®, a probe-based Confocal Laser Endomicroscopy (pCLE) system, provides physicians and researchers high-resolution cellular views of tissue inside the body. Large, international, multicenter clinical trials have demonstrated Cellvizio's ability to help physicians more accurately detect early forms of disease and make treatment decisions immediately. Designed to improve patient outcomes and reduce costs within a hospital, Cellvizio can be used with almost any endoscope. Cellvizio has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-Mark for use in the GI tract, biliary and pancreatic ducts and lungs..

For more information on Mauna Kea Technologies, visit www.maunakeatech.com

United States
Lazar Partners Ltd.
Erich Sandoval
Tél: [phone]
[e-mail]
Mauna Kea Technologies
Eric Cohen
Vice President Finance
Tél: [phone]
[e-mail]
France and Europe
ALIZE RP
Caroline Carmagnol
Tél : + 33 1 42 68 86 43 / + 33 6 64 18 99 59
[e-mail]
NewCap.
Investor Relations & Financial Communication
Florent Alba / Pierre Laurent
Tél : [phone]
[e-mail]